Director, Clinical Thought Leader Liaison

Location: Boston, MA
Reports to: VP of Commercial Operations, USThe Company

Orchard Therapeutics is a leading global, fully integrated, commercial-stage biotech dedicated to transforming the lives of patients with rare diseases through innovative gene therapies.

Partnering with world-leading research institutions in gene therapy, Orchard's portfolio of autologous ex vivo gene therapy programs has demonstrated sustained clinical benefit in over 150 patients across five disease areas. These programs include Strimvelis®, the first autologous ex vivo gene therapy approved by the EMA in 2016, 3 programs in advanced registrational studies in MLD (metachromatic leukodystrophy), WAS (Wiskott Aldrich syndrome) and ADA-SCID (adenosine deaminase severe combined immunodeficiency), 2 other clinical programs in X-CGD (X-linked chronic granulomatous disease) and betathalassemia, as well as an extensive preclinical pipeline

Orchard is a publicly traded company (NASDAQ: ORTX) with offices in the UK and the US, including London, San Francisco and Boston.

Job Summary

The Director of Clinical Specialist (CS) provides key clinical leadership across the country to support commercial goals and objectives. The Clinical Specialist's primary responsibility is to support key US Commercial Strategic Imperatives: identifying patients with ADA-SCID or MLD generating demand with treating physicians, ensuring appropriate utilization and access to treatment. The incumbent will support these strategic imperatives through disease and diagnostics education of Health Care Providers and patients in the therapeutic area across the nation.

Primary Responsibilities

Leading the strategic partnership with the US Sales organization

Leading strategic initiatives geared towards developing external support with HCPs

Identifying and developing Key Opinion Leaders (KOLs)

Collaborate with the VP of Commercial Operations to identify and develop Plan of Action for Prioritized KOLs nationally
(MDs, RNs, mid-levels, GC's)

Train KOLs on approved Disease, Diagnosis and treatment educational material through development of speakers bureau
when approved

Build and maintain strong relationships with KOLs across the country to provide ongoing, new clinical information

Ensures cooperative collaborative communication with cross functional teams (marketing, sales management, sales,
diagnostic, patient services and medical affairs)

Identifying and facilitating disease, diagnosis and treatment case studies

Recruitment and Follow up with HCP and Patient advisory board attendees

Work as key contact with agency on SOWs and building data content for ad board slide library

Manage budgets outlined in SOWs

Review slides with all faculty prior to advisory boards

Collaborate with cross functional teams to identify patients across the country that represent opportunities for targeted case
study development that may eventually be used for educational or publication purposes

Collaborate with internal departments on educational programs, tools and messages

Assist in developing slide decks to be presented during programs and speaker training events

Work closely with US/Global Marketing to provide feedback on educational campaign and/or specific tactics/resources for
patient and HCP advisory boards, marketing materials, slide presentations utilized by KOL's and CTL team.

Involvement in sales training as clinical expert and development of training tools

Continuous assessment of needed training and/or training materials for CTL team

Achieves or exceeds objectives in all regions across the country

Develops, Leads and Facilitates meetings where appropriate

Conducts regular business reviews with senior leadership to ensure attainment of corporate objectives, alignment of goals,
and personal development plans of employees.

Conducts, semi-annual performance reviews to provide accurate and timely feedback regarding goal attainment and
professional development.

Requirements

Education and Training

• B.A./B.S. in business or scientific field is required.
• Master's or Healthcare Degree (NP, PA-C,RN) with previous clinical experience preferred

Skills/Previous Experience

• 8 plus years' experience in pharmaceutical industry, with significant biotech experience required.
• The CTL will comply with all laws, regulations and policies that govern the conduct of activities in general and this role in particular.
• Experience in specialty sales, with paediatric haematology, neurology/genetics and/or rare disease experience preferred.
• 5+ years field-based experience in biopharmaceutical industry preferred
• Proven track record of delivering results that meet or exceed targeted objectives
• Market knowledge preferred: Accounts, KOLs, Referral patterns
• Effective verbal and written communication and organizational abilities.
• Demonstrates strong in-depth clinical, technical and scientific knowledge in complex disease state.
• Valid driver's license and clean driving record
• Deliver Presentations to Executive Leadership Team

For more information, please contact [email protected]

Orchard Therapeutics is an Equal Opportunity, Affirmative Action employer. Minorities, women, veterans, and individuals with disabilities are encouraged to apply.

Notice to All Applicants: Orchard Therapeutics participates in E-Verify

RECRUITERS

All employment offers and CV's are managed through our Human Resources Department and all candidates are presented through this avenue. Therefore, the Human Resources Department at Orchard Therapeutics requests that recruiters are not to contact Orchard Therapeutics employees directly to present candidates. Complying with this request will be a factor in determining future professional relationships with Orchard Therapeutics. Orchard Therapeutics will not accept unsolicited resumes from any source other than directly from candidates for either current or future positions. Submission of unsolicited resumes in advance of an agreement between the Human Resources Department and the recruiter does not create any implied obligation on the part of Orchard Therapeutics.